ATRA vs REGN: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
ATRA
Atara Biotherapeutics Inc
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | ATRA | REGN | Winner |
|---|---|---|---|
| Market Cap | $87.13M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ATRA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or REGN a better investment?
Comparing ATRA and REGN: Atara Biotherapeutics Inc has a market cap of $87.13M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and REGN?
ATRA (Atara Biotherapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ATRA or REGN?
Both ATRA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ATRA or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ATRA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $87.13M for ATRA.
Should I buy ATRA or REGN in 2026?
Both ATRA and REGN have investment merit. ATRA trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and REGN stock?
Key differences: Market Cap ($87.13M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ATRA or REGN in 2026?
The choice between ATRA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ATRA and REGN?
ATRA (Atara Biotherapeutics Inc) has a market cap of $87.13M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.